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of hypertrophic chondrocytes. Cell 93:411–422, 1998]. We then
asked whether the antiapoptotic role of MMP-9 observed dur-
ing renal development could extend to renal pathology. Since
there is no renal alteration in 3-month-old MMP-9–deficient
mice, we used those mice and control mice to induce an acute re-
nal failure by intraperitoneal injection of folic acid. This model is
characterized by an apoptotic phase 12 to 24 hours after the folic
acid injection [Ortiz A, Lorz C, Catalan MP, et al: Expression of
apoptosis regulatory proteins in tubular epithelium stressed in
culture or following acute renal failure. Kidney Int 57:969–981,
2000]. Therefore, we compared kidneys from MMP-9–deficient
mice and control mice 18 hours after folic acid injection. Both
groups of mice developed renal failure of equal severity. MMP-
9 activity was markedly increased in control mice, suggesting an
effect of this enzyme. Indeed, renal lesions were more severe in
MMP-9–deficient mice in which the number of dilated tubules
was increased and the number of apoptotic cell was raised by
two- to threefold in cortex, medulla, and papilla. In summary,
MMP-9–deficient mice exhibit increased extent of apoptosis in
the folic acid model of acute renal failure as well as in kidney
development. We are currently investigating the MMP-9 anti-
apoptotic mode of action.
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The glial cell line–derived neurotrophic factor (GDNF)/
rearrangement during transfection, tyrosine kinase (RET) sig-
naling is recognized as a critical pathway of renal branching mor-
phogenesis, and much attention has been paid to the molecules
that function upstream of this pathway. It was suggested that
transcription factors, Pax2 and Eya-1, are responsible for Gdnf
expression, and Foxc1 prevents ectopic ureteric budding from
Wolffian duct by repressing Gdnf and Eya1. In addition, vitamin
A signal from stromal mesenchyme is necessary for Ret expres-
sion. Recently it was reported that Wnt11 and Sprouty proteins
are associated with the GDNF/RET signaling, but the detailed
process downstream of the GDNF/RET signaling in renal de-
velopment is still poorly understood. We performed an exhaus-
tive analysis of GDNF-inducible genes by differential display
to identify an important molecule which function downstream
of the GDNF/RET signaling pathway. As a consequence, we
found the increased expression of 14 genes by GDNF. Among
them, we focused on a new gene with a BTB/POZ domain and
C2H2-type zinc finger motifs that was named GZF1 (GDNF-
inducible zinc finger gene 1). To elucidate the importance of
GZF1 on kidney development, we stained the mouse embry-
onic kidney with anti-GZF1 antibody. Interestingly, the ureteric
bud epithelia of embryonic metanephroi were strongly stained,
whereas S-shaped or comma-shaped bodies were not stained.
Using serial sections, we detected the expression of GZF1 and
RET in the same ureteric buds. Furthermore, antisense oligonu-
cleotides (ODNs) of the Gzf1 markedly impaired the ureteric
bud branching in the metanephric organ culture, suggesting that
the induction of GZF1 via the GDNF/RET signaling system is
required for renal branching morphogenesis. We investigated
the transcriptional activity of GZF1 by luciferase reporter gene
assay. In this assay, it was revealed that the GZF1 possesses tran-
scriptional repressive activity. To examine the binding sequence
for GZF1, we employed cyclic amplification and selection of
targets (CASTing). Finally, a consensus sequence was derived
from the sequence alignment of individual clones. We named it
GZF1 recognition element (GRE). Next we searched for po-
tential target genes that might be regulated by GZF1 and found
that a variety of genes possess the GRE in their 5’ upstream reg-
ulatory region. We are now investigating the effect of the GRE
on the promoter activity of one gene among them. To examine
whether the GZF1 binds the promoter region of this gene, we
performed modified chromatin immunoprecipitation assay. It
was shown that GZF1 binds the promoter region of this gene.
Further analysis about the transcriptional effect of GZF1 on this
gene is now moving. As described above, this novel gene GZF1
may play a crucial role in renal development regulated by the
GDNF/RET signaling. We are now generating Gzf1−/− mouse.
We expect this novel molecule will promote our understanding
of the mechanisms of the renal organogenesis. Furthermore, its
clinical application to the treatment of renal disease, especially
to the regeneration of the kidney, should be explored in the
future.
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